Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer

PURPOSE: On the basis of the ACCORD trial, FOLFIRINOX is effective in metastatic pancreatic adenocarcinoma (PDAC), making it a rational choice for locally advanced PDAC (LA). Aims of this study are to evaluate the accuracy of imaging in determining the resectability of PDAC and to determine the surg...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Surg
Главные авторы: Ferrone, Cristina R., Marchegiani, Giovanni, Hong, Theodore S., Ryan, David P., Deshpande, Vikram, McDonnell, Erin I., Sabbatino, Francesco, Santos, Daniela Dias, Allen, Jill N., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Faris, Jason E., Goyal, Lipika, Kwak, Eunice L., Murphy, Janet E., Ting, David T., Wo, Jennifer Y., Zhu, Andrew X., Warshaw, Andrew L., Lillemoe, Keith D., Castillo, Carlos Fernández-del
Формат: Artigo
Язык:Inglês
Опубликовано: 2015
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349683/
https://ncbi.nlm.nih.gov/pubmed/25599322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SLA.0000000000000867
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы